Monica B. Norton - Concepedia

Author

Monica B. Norton

Also Known As

Monica B. Norton

Publications

333

Citations

H-Index

Concepts

All Affiliations

Monica B. Norton is an author at Monsanto (United States) specializing in drug discovery, medicine, and pharmacology.

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	306
2	Pharmacology	5	5	306
3	Natural Sciences	3	3	167
4	Biochemistry	3	3	167
5	Clinical Pharmacology	1	1	118

Monica B. Norton

Publications

306

Citations

H-Index

Page 1

	Year	Citations
Selective Cyclooxygenase Inhibitors: Novel 1,2-Diarylcyclopentenes Are Potent and Orally Active COX-2 Inhibitors David B. Reitz, James J. Li, Monica B. Norton, Journal of Medicinal Chemistry Altmetric Attention ScorePharmacotherapyPre-clinical PharmacologyDrug ResistanceSystems Pharmacology	1994	118
Novel Terphenyls as Selective Cyclooxygenase-2 Inhibitors and Orally Active Anti-inflammatory Agents James J. Li, Monica B. Norton, Emily J. Reinhard, Journal of Medicinal Chemistry Terphenyl Methyl SulfonesPharmaceutical SciencePharmacotherapySelective Cyclooxygenase-2 InhibitorsPharmaceutical Chemistry	1996	106
Discovery of a Simple Picomolar Inhibitor of Cholesteryl Ester Transfer Protein Emily J. Reinhard, Jane L. Wang, Richard C. Durley, Journal of Medicinal Chemistry Lower PotencyMedicinal ChemistryOxysterolBiochemistryPotency Relative	2003	48
N1-sterically hindered 2H-imidazol-2-one angiotensin II receptor antagonists: The conversion of surmountable antagonists to insurmountable antagonists David B. Reitz, Danny J. Garland, Monica B. Norton, Bioorganic & Medicinal Chemistry Letters Surmountable AntagonistsMedicinePhysiologyCardiovascular PharmacologyMechanism Of Action	1993	21
Novel 1,2-diarylcyclopentenes are selective, potent, and orally active cyclooxygenase inhibitors David B. Reitz, James J. Li, Monica B. Norton, Medicinal Chemistry Research Medicinal ChemistryBiochemistryMedicineNatural SciencesMechanism Of Action	1995	13

Page 1